TotalMarketCap

Kyntra Bio

KYNBNasdaq United StatesHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$14.820 M

$3.66 -7.58%

Close of 6 Nov 2026

As of 6 Nov 2026, Kyntra Bio (KYNB) has a market capitalization of $14.8M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

$6.44M

#3220 by revenue

Earnings

$183.5M

#1037 by earnings

Shares outstanding

4,049,124

Latest filing cover page

P/E ratio

0.1

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →
  1. #397Neuphoria TherapeuticsNEUP$15.1M
  2. #398Marker TherapeuticsMRKR$14.9M
  3. #399Kyntra BioKYNB$14.8M
  4. #400Optimi HealthOPTH$13.5M
  5. #401Radiopharm TheranosticsRADX$12.9M

What if Kyntra Bio were worth as much as…

Open the what-if tool →

Gold $28.2T

$6,973,576

Per share 1,905,349× higher

Bitcoin $1.53T

$377,328.05

Per share 103,095× higher

Apple $5.02T

$1,238,733

Per share 338,452× higher

Or at a round number

$20.0M$50.0M$100.0M$200.0M

Where these numbers come from

Share counts and financials for Kyntra Bio are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.